NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Recruiting · NCT07114874 · Interventional (participants receive a specific treatment) · Lead sponsor: Neurocrine Biosciences
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Participant has a primary diagnosis of schizophrenia
- Participants taking prohibited medications, including antipsychotics, must discontinue before study participation
- Participant must reside in a stable housing situation
- Key
Exclusion criteria
- Participant has known hypersensitivity to any component of the formulation of NBI-1117568
- Participant has an unstable or poorly controlled medical condition or chronic disease
- Participant is considered by the investigator to be at imminent risk of suicide or injury to self or others
- Participant has a diagnosis of moderate or severe substance use disorder (with the exception of nicotine or caffeine dependence) within 6 months prior to screening
- Participant has a positive alcohol test or drug screen for disallowed substances
- Participant has a history of poor or suspected poor compliance in clinical research studies and/or in the investigator's opinion, the participant is not capable of adhering to the protocol requirements.
- Note: Other protocol-specified inclusion/exclusion criteria may apply.
Where it is running
57 locations listed across 16 US states.
- Neurocrine Clinical Site - Bryant, Arkansas, United States
- Neurocrine Clinical Site - Little Rock, Arkansas, United States
- Neurocrine Clinical Site - Cerritos, California, United States
- Neurocrine Clinical Site - Chino, California, United States
- Neurocrine Clinical Site - Culver City, California, United States
- Neurocrine Clinical Site - Garden Grove, California, United States
- Neurocrine Clinical Site - La Habra, California, United States
- Neurocrine Clinical Site - Lemon Grove, California, United States
- Neurocrine Clinical Site - Oceanside, California, United States
- Neurocrine Clinical Site - Pico Rivera, California, United States
- Neurocrine Clinical Site - Riverside, California, United States
- Neurocrine Clinical Site - San Diego, California, United States
- Neurocrine Clinical Site - Sherman, California, United States
- Neurocrine Clinical Site - Torrance, California, United States
- Neurocrine Clinical Site - West Hills, California, United States
- Neurocrine Clinical Site - Atlantis, Florida, United States
- Neurocrine Clinical Site - Aventura, Florida, United States
- Neurocrine Clinical Site - Doral, Florida, United States
- Neurocrine Clinical Site - Hollywood, Florida, United States
- Neurocrine Clinical Site - Maitland, Florida, United States
- Neurocrine Clinical Site - Miami, Florida, United States
- Neurocrine Clinical Site - Miami, Florida, United States
- Neurocrine Clinical Site - Miami Lakes, Florida, United States
- Neurocrine Clinical Site - Tampa, Florida, United States
- Neurocrine Clinical Site - West Palm Beach, Florida, United States
- Neurocrine Clinical Site - Atlanta, Georgia, United States
- Neurocrine Clinical Site - Atlanta, Georgia, United States
- Neurocrine Clinical Site - Decatur, Georgia, United States
- Neurocrine Clinical Sites - Peachtree Corners, Georgia, United States
- Neurocrine Clinical Site - Chicago, Illinois, United States
- Neurocrine Clinical Site - Gaithersburg, Maryland, United States
- Neurocrine Clinical Site - Boston, Massachusetts, United States
- Neurocrine Clinical Site - Watertown, Massachusetts, United States
- Neurocrine Clinical Site - Flowood, Mississippi, United States
- Neurocrine Clinical Site - St Louis, Missouri, United States
- Neurocrine Clinical Site - Marlton, New Jersey, United States
- Neurocrine Clinical Site - Cedarhurst, New York, United States
- Neurocrine Clinical Site - New York, New York, United States
- Neurocrine Clinical Site - New York, New York, United States
- Neurocrine Clincial Site - Staten Island, New York, United States
- Neurocrine Clinical Sites - The Bronx, New York, United States
- Neurocrine Clinical Sites - North Canton, Ohio, United States
- Neurocrine Clinical Site - Philadelphia, Pennsylvania, United States
- Neurocrine Clinical Site - Austin, Texas, United States
- Neurocrine Clinical Site - DeSoto, Texas, United States
- Neurocrine Clinical Site - Houston, Texas, United States
- Neurocrine Clinical Sites - Orem, Utah, United States
- Neurocrine Clinical Site - Orem, Utah, United States
- Neurocrine Clinical Site - Bellevue, Washington, United States
- Neurocrine Clinical Site - Belgrade, Serbia
- Neurocrine Clinical Site - Brasov, Romania
- Neurocrine Clinical Site - Bucharest, Romania
- Neurocrine Clinical Site - Gornja Toponica, Serbia
- Neurocrine Clinical Site - Kragujevac, Serbia
- Neurocrine Clinical Site - Sânpetru, Romania
- Neurocrine Clinical Site - Veliko Tarnovo, Bulgaria
- Neurocrine Clinical Site - Vratsa, Bulgaria